Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing

8 Sept 2022

Abstract excerpt

BACKGROUND: There is a growing need for genetic testing of women with epithelial ovarian cancer. Mainstream genetic testing provides an alternative care pathway in which non-genetic healthcare professionals offer pre-test counseling themselves. We aimed to explore the impact of mainstream genetic testing on patients' experiences, turnaround times and adherence of non-genetic healthcare professionals to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genetic factors in colorectal cancer
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36076240
DOI: 10.1186/s13053-022-00238-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 16 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testingPMID 36076240Read ↗

Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.Semantic proximity Read ↗

Obstacles in genetic testing for germline BRCA1/2 pathogenic mutations in patients with primary breast and ovarian cancer in Switzerland.Semantic proximity Read ↗

Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancerSemantic proximity Read ↗

Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer.Semantic proximity Read ↗

Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspectiveSemantic proximity Read ↗

Mainstreamed genetic testing in ovarian cancer: patient experience of the testing processSemantic proximity Read ↗

The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing.Semantic proximity Read ↗

Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing.Semantic proximity Read ↗

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomesSemantic proximity Read ↗

Breast cancer patients' experiences and outcomes of mainstream genetic testing with and without genetic counseling.Semantic proximity Read ↗

Psychosocial experiences and outcomes for individuals with breast cancer after mainstream genetic testingSemantic proximity Read ↗

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.